Enochian Biosciences (ENOB) Peer Comparison

$1.56

$0.86 (122.86%)

As on 11-Aug-2023 09:30EDT

Market cap

$31 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.4

Div. Yield

0 %

Edit

	Enochian Biosciences (ENOB)	Verona Pharma - ADR
Market cap ($ Mln)	31	9,085
Revenue ($ Mln)	--	168
Net Profit ($ Mln)	-387,426.79	-63.10
Net Margin (%)	93,681,140.44	-37.64
RoE (%)	-567,853.84	-26.14
Price to Earnings	--	--
Price-To-Book	0.45	33.01

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Enochian Biosciences (ENOB)	Verona Pharma - ADR
Operating Revenue	0.00	0.38
Cost of Revenue	0.00	0.29
Gross Profit	--	0.09
Operating Expenses	21.17	62.75
Operating Profit (EBIT)	-114.42	-62.66
Other Income	-0.41	--
Profit before Tax	-192.50	-56.62
Provision for Tax	387,234.29	-0.21
Profit after Tax (Net Income)	-387,426.79	-56.83
Minority Interest	0.00	--
Consolidated Profit	-12.03	-68.70

Liabilities ($ Mln)

	Enochian Biosciences (ENOB)	Verona Pharma - ADR
Shareholder's Funds	66.13	230.47
Minority Interest	0.00	--
Non-Current Liabilities	0.83	9.97
Current Liabilities	11.77	19.03
Total Liabilities	84.63	259.47

Assets ($ Mln)

	Enochian Biosciences (ENOB)	Verona Pharma - ADR
Non-Current Assets	74.80	16.47
Current Assets	3.93	243.00
Total Assets	--	259.47
Total Debt*	7.04	10.65
Net Current Assets	-7.85	223.97

Cashflow ($ Mln)

	Enochian Biosciences (ENOB)	Verona Pharma - ADR
Cash From Operating Activities	-15.73	-59.86
Cash Flow from Investing Activities	--	-0.03
Cash from Financing Activities	4.25	140.82
Net Cash Inflow / Outflow	--	--

Ratios

Profitability Ratios

	Enochian Biosciences (ENOB)	Verona Pharma - ADR
ROCE (%)	-89.11	-28.78
ROE (%)	-567,853.84	-30.03
ROA (%)	-278,607.70	-25.48
EBIT Margin (%)	--	--
Net Margin (%)	93,681,140.44	-15,000.25
Cash Profit Margin (%)	--	--

Growth Ratios

	Enochian Biosciences (ENOB)	Verona Pharma - ADR
Revenue Growth (%)	--	-0.99
EBIT Growth (%)	-219.06	--
Net Profit Growth (%)	-904,983.19	-38.30
EPS Growth (%)	-808,409.18	-0.10
Book Value Growth (%)	-61.19	--

Valuation Ratios

	Enochian Biosciences (ENOB)	Verona Pharma - ADR
Price / Earnings	-0.90	-34.73
Price / Book Value	1.41	8.56
Dividend Yield (%)	--	--
EV/EBITDA	-0.82	-32.42
Market Cap ($ Cr)	--	--

Solvency Ratios

	Enochian Biosciences (ENOB)	Verona Pharma - ADR
Debt to Equity	0.00	0.05
Short term debt to equity ratio	0.09	0.00
Current Ratio	0.33	12.77
Quick Ratio	0.33	12.64
Interest Coverage	-349.34	-104.98

Operating Efficiency Ratios

	Enochian Biosciences (ENOB)	Verona Pharma - ADR
Debtors to sales (%)	--	2,449.94
Asset Turnover	0.00	0.00
Receivable days	--	11,985.69
Inventory Days	--	4,170.38
Payable days	--	8,265.46
Cash Conversion Cycle	--	7,890.60

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly